Growth InvestmentTo support long-term growth and expand market share, TMO announced plans to invest US$2bn over the next four years in expanding its US manufacturing and R&D facilities, in response to growing customer demand.
Market ShareThere is continued appreciation for Thermo's ability to gain market share in some areas, such as contract manufacturing and research distribution, and constructive trends in some business segments like drug production.
Transaction AdvantagesThe purchase price is effectively reduced by approximately $175 million, providing a financial advantage to TMO.